Fennec Pharmaceuticals Inc (FRX.TO)
9.85
+0.10
(+1.03%)
CAD |
TSX |
May 22, 15:59
Fennec Pharmaceuticals Price to Book Value: 65.95 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 65.28 |
| May 17, 2024 | 63.67 |
| May 16, 2024 | 62.47 |
| May 15, 2024 | 63.74 |
| May 14, 2024 | 67.09 |
| May 13, 2024 | 91.86 |
| May 10, 2024 | 90.19 |
| May 09, 2024 | 84.68 |
| May 08, 2024 | 84.68 |
| May 07, 2024 | 84.68 |
| May 06, 2024 | 83.68 |
| May 03, 2024 | 84.21 |
| May 02, 2024 | 84.21 |
| May 01, 2024 | 84.21 |
| April 30, 2024 | 84.21 |
| April 29, 2024 | 84.21 |
| April 26, 2024 | 83.56 |
| April 25, 2024 | 85.02 |
| April 24, 2024 | 85.02 |
| April 23, 2024 | 85.02 |
| April 22, 2024 | 85.02 |
| April 19, 2024 | 85.15 |
| April 18, 2024 | 91.46 |
| April 17, 2024 | 91.46 |
| April 16, 2024 | 95.12 |
| Date | Value |
|---|---|
| April 15, 2024 | 94.32 |
| April 12, 2024 | 96.58 |
| April 11, 2024 | 96.58 |
| April 10, 2024 | 96.51 |
| April 09, 2024 | 97.44 |
| April 08, 2024 | 99.63 |
| April 05, 2024 | 99.63 |
| April 04, 2024 | 99.63 |
| April 03, 2024 | 99.90 |
| April 02, 2024 | 99.90 |
| April 01, 2024 | 100.30 |
| March 31, 2024 | |
| March 28, 2024 | |
| March 27, 2024 | |
| March 26, 2024 | |
| March 25, 2024 | |
| March 22, 2024 | |
| March 21, 2024 | |
| March 20, 2024 | |
| March 19, 2024 | |
| March 18, 2024 | |
| March 15, 2024 | |
| March 14, 2024 | |
| March 13, 2024 | |
| March 12, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.361
Minimum
Sep 04 2020
100.30
Maximum
Apr 01 2024
17.59
Average
8.182
Median
Aug 09 2021
Price to Book Value Benchmarks
| Ionic Brands Corp | -- |
| 4Front Ventures Corp | -- |
| Green Thumb Industries Inc | 1.691 |
| Lowell Farms Inc | 0.1565 |
| Bright Minds Biosciences Inc | 1.256 |
Price to Book Value Related Metrics
| PE Ratio | 243.94 |
| PS Ratio | 4.500 |
| Price to Free Cash Flow | 7.371 |
| Price | 9.85 |
| Earnings Yield | 0.41% |
| Market Cap | 269.12M |
| Operating PE Ratio | 33.31 |
| Normalized PE Ratio | 232.83 |